Harvard Bioscience Statistics

Total Valuation

HBIO has a market cap or net worth of $33.78 million. The enterprise value is $69.75 million.

Market Cap	33.78M
Enterprise Value	69.75M

Important Dates

The last earnings date was Thursday, November 6, 2025, before market open.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

HBIO has 44.58 million shares outstanding. The number of shares has increased by 2.01% in one year.

Current Share Class	44.58M
Shares Outstanding	44.58M
Shares Change (YoY)	+2.01%
Shares Change (QoQ)	+0.57%
Owned by Insiders (%)	7.75%
Owned by Institutions (%)	28.14%
Float	34.30M

Valuation Ratios

PE Ratio	n/a
Forward PE	8.91
PS Ratio	0.38
Forward PS	0.37
PB Ratio	2.40
P/TBV Ratio	n/a
P/FCF Ratio	4.54
P/OCF Ratio	3.95
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.99, with an EV/FCF ratio of 9.37.

EV / Earnings	n/a
EV / Sales	0.80
EV / EBITDA	13.99
EV / EBIT	n/a
EV / FCF	9.37

Financial Position

The company has a current ratio of 0.81, with a Debt / Equity ratio of 3.04.

Current Ratio	0.81
Quick Ratio	0.35
Debt / Equity	3.04
Debt / EBITDA	5.87
Debt / FCF	5.75
Interest Coverage	-0.40

Financial Efficiency

Return on equity (ROE) is -135.62% and return on invested capital (ROIC) is -1.02%.

Return on Equity (ROE)	-135.62%
Return on Assets (ROA)	-0.82%
Return on Invested Capital (ROIC)	-1.02%
Return on Capital Employed (ROCE)	-5.80%
Revenue Per Employee	$246,115
Profits Per Employee	-$151,648
Employee Count	355
Asset Turnover	0.84
Inventory Turnover	1.58

Taxes

In the past 12 months, HBIO has paid $243,000 in taxes.

Income Tax	243,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -66.47% in the last 52 weeks. The beta is 1.54, so HBIO's price volatility has been higher than the market average.

Beta (5Y)	1.54
52-Week Price Change	-66.47%
50-Day Moving Average	0.54
200-Day Moving Average	0.51
Relative Strength Index (RSI)	64.70
Average Volume (20 Days)	1,283,126

Short Selling Information

The latest short interest is 1.38 million, so 3.09% of the outstanding shares have been sold short.

Short Interest	1.38M
Short Previous Month	7.05M
Short % of Shares Out	3.09%
Short % of Float	4.02%
Short Ratio (days to cover)	0.09

Income Statement

In the last 12 months, HBIO had revenue of $87.37 million and -$53.84 million in losses. Loss per share was -$1.22.

Revenue	87.37M
Gross Profit	49.79M
Operating Income	-1.37M
Pretax Income	-53.59M
Net Income	-53.84M
EBITDA	4.99M
EBIT	-1.37M
Loss Per Share	-$1.22

Full Income Statement

Balance Sheet

The company has $6.82 million in cash and $42.79 million in debt, giving a net cash position of -$35.97 million or -$0.81 per share.

Cash & Cash Equivalents	6.82M
Total Debt	42.79M
Net Cash	-35.97M
Net Cash Per Share	-$0.81
Equity (Book Value)	14.07M
Book Value Per Share	0.32
Working Capital	-10.59M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $8.55 million and capital expenditures -$1.11 million, giving a free cash flow of $7.44 million.

Operating Cash Flow	8.55M
Capital Expenditures	-1.11M
Free Cash Flow	7.44M
FCF Per Share	$0.17

Full Cash Flow Statement

Margins

Gross margin is 56.99%, with operating and profit margins of -1.57% and -61.62%.

Gross Margin	56.99%
Operating Margin	-1.57%
Pretax Margin	-61.34%
Profit Margin	-61.62%
EBITDA Margin	5.71%
EBIT Margin	-1.57%
FCF Margin	8.52%

Dividends & Yields

HBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.01%
Shareholder Yield	-2.01%
Earnings Yield	-159.38%
FCF Yield	22.03%

Analyst Forecast

The average price target for HBIO is $2.50, which is 229.95% higher than the current price. The consensus rating is "Buy".

Price Target	$2.50
Price Target Difference	229.95%
Analyst Consensus	Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HBIO has an Altman Z-Score of -2.44 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.44
Piotroski F-Score	3